
Summary The HIV-1 reservoir is composed of cells harboring latent proviruses that are capable of contributing to viremia upon antiretroviral treatment ( ART) interruption. Although this reservoir is known to be maintained by clonal expansion, the contribution of large, infected cell clones to residual viremia and viral rebound remains underexplored. Here, we conducted an extensive analysis on four ART-treated individuals who underwent an analytical treatment interruption ( ATI ). We performed subgenomic (V1-V3 env ), near full-length proviral and integration site sequencing, and used multiple displacement amplification to sequence both the integration site and provirus from single HIV-infected cells. We found eight proviruses that could phylogenetically be linked to plasma virus obtained before or during the ATI. This study highlights a role for HIV-infected cell clones in the maintenance of the replication-competent reservoir and suggests that infected cell clones can directly contribute to rebound viremia upon ATI.
CD4(+) T-CELLS, CD4-Positive T-Lymphocytes, antiretroviral therapy, Genetics and Molecular Biology, rebound, HIV Infections, clonal expansion, PROVIRUSES, 0601 Biochemistry and Cell Biology, Article, LATENT RESERVOIR, POOL, ANTIRETROVIRAL THERAPY, Proviruses, replication competency, INTACT HIV-1, HIV Seropositivity, Medicine and Health Sciences, Humans, Viremia, latency, cellular proliferation, Science & Technology, IDENTIFICATION, 31 Biological sciences, full-length HIV sequencing, PROLIFERATION, CP: Microbiology, HIV, Cell Biology, Virus Latency, analytical treatment interruption, integration site sequencing, VIRUS TYPE-1 VIREMIA, Anti-Retroviral Agents, 1116 Medical Physiology, General Biochemistry, REPLICATION, HIV-1, Life Sciences & Biomedicine
CD4(+) T-CELLS, CD4-Positive T-Lymphocytes, antiretroviral therapy, Genetics and Molecular Biology, rebound, HIV Infections, clonal expansion, PROVIRUSES, 0601 Biochemistry and Cell Biology, Article, LATENT RESERVOIR, POOL, ANTIRETROVIRAL THERAPY, Proviruses, replication competency, INTACT HIV-1, HIV Seropositivity, Medicine and Health Sciences, Humans, Viremia, latency, cellular proliferation, Science & Technology, IDENTIFICATION, 31 Biological sciences, full-length HIV sequencing, PROLIFERATION, CP: Microbiology, HIV, Cell Biology, Virus Latency, analytical treatment interruption, integration site sequencing, VIRUS TYPE-1 VIREMIA, Anti-Retroviral Agents, 1116 Medical Physiology, General Biochemistry, REPLICATION, HIV-1, Life Sciences & Biomedicine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 32 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
